Hair Growth Claims Move Your Serum Into Drug Territory
Regrowth and hair-loss-treatment wording pushes a scalp serum out of cosmetic notification and onto a completely different drug pathway.
Regrowth and hair-loss-treatment wording pushes a scalp serum out of cosmetic notification and onto a completely different drug pathway.
Salicylic acid and benzoyl peroxide show exactly where an acne-treatment claim moves a face wash out of cosmetic notification and into drug territory.
Why UV filters sit on Canada's Hotlist and why using them can quietly push a product out of cosmetic territory and into drug rules.
Saying your serum treats acne, not just oily skin, can shift it out of cosmetic territory entirely. Here is where that line sits.
How azelaic acid's INCI name, CAS 123-99-9, and the claim you attach to it decide whether you're filing a CNF or a drug submission.
Why a plain shave cream files as a cosmetic in Canada, and how one antibacterial or medicated claim can push the same product into drug territory.
Words like healing, eczema relief, or clears psoriasis on a soap label can quietly turn a cosmetic into an unregistered drug.
Where a lash serum's claims quietly cross from a conditioning cosmetic into drug territory, and why the wording matters more than the formula.
Why saying your soap kills germs can turn it into a drug overnight, and what wording keeps it a cosmetic instead.
A softening foot cream is a cosmetic. An antifungal or callus-removal one is a drug. The label claim decides which.
How specific marketing claims reclassify a US cosmetic as an OTC drug, with the tighter substantiation rules that follow.
Salicylic acid can sit in a cosmetic exfoliant or push a product into drug territory depending on concentration and claim. Here is the CAS, INCI, and the line.